Development of phenylpropanoid sucrose esters as antidiabetic lead compounds
Alpha-glucosidase inhibitors (AGIs), particularly Acarbose, have received increased attention in the treatment of Type 2 diabetes (T2D) due to their effectiveness in managing postprandial blood glucose and associated macrovascular and microvascular health complications. However, AGIs are commonly pl...
Saved in:
Main Author: | Ong, Li Lin |
---|---|
Other Authors: | Zaher Judeh |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/106085 http://hdl.handle.net/10220/47906 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Investigation of phenylpropanoid sucrose esters as antidiabetic compounds
by: Wong, Kathy Pooi Wen
Published: (2020) -
Development of phenylpropanoid sucrose esters (PSEs) as lead drug candidates for alpha glucosidase inhibition
by: Devaraj, Surabhi
Published: (2017) -
Synthesis and anticancer activity of phenylpropanoid sucrose esters
by: Parthasarathi Panda
Published: (2015) -
An orthogonal approach for the precise synthesis of phenylpropanoid sucrose esters
by: Ong, Li Lin, et al.
Published: (2022) -
Targeted synthesis of 3,3'-, 3,4'- and 3,6'-phenylpropanoid sucrose esters
by: Wong, Kathy Pooi Wen, et al.
Published: (2022)